chr7_+_116166346
|
1.848
|
NM_001172896
NM_001172897
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr7_+_116164838
|
1.792
|
NM_001753
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr7_+_116165043
|
1.783
|
NM_001172895
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr3_-_134093235
|
0.739
|
NM_016201
|
AMOTL2
|
angiomotin like 2
|
chr6_+_21593963
|
0.710
|
NM_003107
|
SOX4
|
SRY (sex determining region Y)-box 4
|
chr15_+_39873276
|
0.529
|
NM_003246
|
THBS1
|
thrombospondin 1
|
chr19_+_16178170
|
0.504
|
NM_001145160
|
TPM4
|
tropomyosin 4
|
chr19_+_16187047
|
0.492
|
NM_003290
|
TPM4
|
tropomyosin 4
|
chr8_-_17555158
|
0.457
|
NM_020749
|
MTUS1
|
microtubule associated tumor suppressor 1
|
chr2_-_56151273
|
0.412
|
NM_001039348
NM_001039349
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
chr8_-_17658385
|
0.411
|
NM_001001924
NM_001001925
|
MTUS1
|
microtubule associated tumor suppressor 1
|
chr5_+_140864626
|
0.384
|
NM_018928
NM_032406
|
PCDHGC4
|
protocadherin gamma subfamily C, 4
|
chr8_-_17580024
|
0.384
|
NM_001166393
|
MTUS1
|
microtubule associated tumor suppressor 1
|
chr5_+_140797243
|
0.378
|
NM_018927
|
PCDHGB7
|
protocadherin gamma subfamily B, 7
|
chr12_+_13349601
|
0.377
|
NM_001423
|
EMP1
|
epithelial membrane protein 1
|
chrX_+_64887510
|
0.376
|
NM_002444
|
MSN
|
moesin
|
chr5_+_140749830
|
0.373
|
NM_018924
NM_032097
|
PCDHGB3
|
protocadherin gamma subfamily B, 3
|
chr8_-_17579729
|
0.372
|
NM_001001931
|
MTUS1
|
microtubule associated tumor suppressor 1
|
chr20_+_19867075
|
0.367
|
NM_001242581
|
RIN2
|
Ras and Rab interactor 2
|
chr5_+_140868721
|
0.364
|
NM_018929
NM_032407
|
PCDHGC5
|
protocadherin gamma subfamily C, 5
|
chr1_-_209979388
|
0.358
|
NM_001206696
NM_006147
|
IRF6
|
interferon regulatory factor 6
|
chr5_+_140810126
|
0.353
|
NM_003735
NM_032094
|
PCDHGA12
|
protocadherin gamma subfamily A, 12
|
chr20_+_19870209
|
0.346
|
NM_018993
|
RIN2
|
Ras and Rab interactor 2
|
chr3_-_57113292
|
0.342
|
NM_001128615
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
chr15_+_85359910
|
0.333
|
NM_020778
|
ALPK3
|
alpha-kinase 3
|
chr5_+_140739589
|
0.332
|
NM_018923
NM_032096
|
PCDHGB2
|
protocadherin gamma subfamily B, 2
|
chr1_-_68299047
|
0.331
|
NM_018841
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
chr6_+_116601282
|
0.327
|
NM_001080976
|
DSE
|
dermatan sulfate epimerase
|
chr3_-_56809594
|
0.316
|
NM_001128616
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
chr11_-_33757872
|
0.315
|
NM_000611
NM_203329
NM_203330
NM_203331
|
CD59
|
CD59 molecule, complement regulatory protein
|
chr5_+_140753480
|
0.308
|
NM_018919
NM_032086
|
PCDHGA6
|
protocadherin gamma subfamily A, 6
|
chr5_+_140729723
|
0.300
|
NM_018922
NM_032095
|
PCDHGB1
|
protocadherin gamma subfamily B, 1
|
chr14_-_105444693
|
0.298
|
NM_138420
|
AHNAK2
|
AHNAK nucleoprotein 2
|
chr6_+_116692098
|
0.295
|
NM_013352
|
DSE
|
dermatan sulfate epimerase
|
chr13_-_110438896
|
0.293
|
NM_003749
|
IRS2
|
insulin receptor substrate 2
|
chr1_+_26606212
|
0.292
|
NM_031286
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3
|
chr3_-_56835829
|
0.289
|
NM_019555
|
ARHGEF3
|
Rho guanine nucleotide exchange factor (GEF) 3
|
chr11_-_33744272
|
0.284
|
NM_001127223
NM_001127225
NM_001127226
|
CD59
|
CD59 molecule, complement regulatory protein
|
chr1_+_182992329
|
0.283
|
NM_002293
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
chr18_-_53255734
|
0.283
|
NM_001083962
NM_001243230
NM_003199
|
TCF4
|
transcription factor 4
|
chr11_-_33744497
|
0.282
|
NM_001127227
|
CD59
|
CD59 molecule, complement regulatory protein
|
chr8_+_42995553
|
0.280
|
NM_152419
|
HGSNAT
|
heparan-alpha-glucosaminide N-acetyltransferase
|
chr5_-_16936371
|
0.273
|
NM_012334
|
MYO10
|
myosin X
|
chr5_+_140718353
|
0.268
|
NM_018915
NM_032009
|
PCDHGA2
|
protocadherin gamma subfamily A, 2
|
chr5_+_140743755
|
0.268
|
NM_018918
NM_032054
|
PCDHGA5
|
protocadherin gamma subfamily A, 5
|
chr5_+_140767402
|
0.260
|
NM_003736
NM_032098
|
PCDHGB4
|
protocadherin gamma subfamily B, 4
|
chr10_+_129705299
|
0.257
|
NM_006504
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
chr11_-_76380894
|
0.256
|
NM_005512
|
LRRC32
|
leucine rich repeat containing 32
|
chr18_+_47088400
|
0.249
|
NM_006033
|
LIPG
|
lipase, endothelial
|
chr11_-_76381787
|
0.247
|
NM_001128922
|
LRRC32
|
leucine rich repeat containing 32
|
chr1_-_204459445
|
0.242
|
NM_002646
|
PIK3C2B
|
phosphoinositide-3-kinase, class 2, beta polypeptide
|
chr10_+_129845806
|
0.240
|
NM_130435
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
chr2_-_235405692
|
0.239
|
NM_005737
|
ARL4C
|
ADP-ribosylation factor-like 4C
|
chr7_-_11871735
|
0.239
|
NM_015204
|
THSD7A
|
thrombospondin, type I, domain containing 7A
|
chr12_+_75874512
|
0.238
|
NM_006851
|
GLIPR1
|
GLI pathogenesis-related 1
|
chrX_-_10588458
|
0.237
|
NM_000381
NM_033289
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr6_+_7727010
|
0.234
|
NM_001718
|
BMP6
|
bone morphogenetic protein 6
|
chr11_+_69455837
|
0.233
|
NM_053056
|
CCND1
|
cyclin D1
|
chrX_-_10544852
|
0.224
|
NM_001193277
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr8_+_1772095
|
0.222
|
NM_014629
|
ARHGEF10
|
Rho guanine nucleotide exchange factor (GEF) 10
|
chrX_-_10645726
|
0.221
|
NM_001098624
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr16_+_66400524
|
0.219
|
NM_001795
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
chr6_+_151646634
|
0.219
|
NM_144497
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
chr10_-_123356158
|
0.218
|
NM_001144915
|
FGFR2
|
fibroblast growth factor receptor 2
|
chr11_+_133938819
|
0.215
|
NM_001205329
NM_032801
|
JAM3
|
junctional adhesion molecule 3
|
chr15_-_63674074
|
0.212
|
NM_001218
NM_206925
|
CA12
|
carbonic anhydrase XII
|
chr7_-_131241321
|
0.212
|
NM_001018111
NM_005397
|
PODXL
|
podocalyxin-like
|
chr6_+_151561094
|
0.211
|
NM_005100
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
chrX_-_10851808
|
0.210
|
NM_033290
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
chr19_-_19754452
|
0.204
|
NM_016573
|
GMIP
|
GEM interacting protein
|
chr12_-_50677238
|
0.201
|
NM_001113546
NM_016357
|
LIMA1
|
LIM domain and actin binding 1
|
chr1_-_163172624
|
0.200
|
NM_001195303
|
RGS5
|
regulator of G-protein signaling 5
|
chr6_+_106959729
|
0.196
|
NM_001624
|
AIM1
|
absent in melanoma 1
|
chr11_+_65339819
|
0.195
|
NM_001098784
NM_001098785
NM_152832
|
FAM89B
|
family with sequence similarity 89, member B
|
chr10_-_123353771
|
0.192
|
NM_001144916
|
FGFR2
|
fibroblast growth factor receptor 2
|
chr21_-_28217692
|
0.190
|
NM_006988
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
chr1_-_16482426
|
0.188
|
NM_004431
|
EPHA2
|
EPH receptor A2
|
chr12_-_50616425
|
0.186
|
NM_001113547
|
LIMA1
|
LIM domain and actin binding 1
|
chr1_-_163172863
|
0.185
|
NM_003617
|
RGS5
|
regulator of G-protein signaling 5
|
chr7_-_30029904
|
0.182
|
NM_001145514
|
SCRN1
|
secernin 1
|
chr12_-_54813010
|
0.181
|
NM_002205
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
chr5_+_40680021
|
0.177
|
NM_000958
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
chr7_-_87856282
|
0.175
|
NM_198901
|
SRI
|
sorcin
|
chr12_+_13043955
|
0.173
|
NM_003979
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
chr2_-_86790533
|
0.173
|
NM_001005753
NM_001193517
NM_016079
|
CHMP3
|
charged multivesicular body protein 3
|
chr5_+_140762401
|
0.171
|
NM_018920
NM_032087
|
PCDHGA7
|
protocadherin gamma subfamily A, 7
|
chr2_-_86948244
|
0.171
|
NM_001198954
|
RNF103-CHMP3
|
RNF103-CHMP3 readthrough
|
chr10_-_105845619
|
0.168
|
NM_000494
|
COL17A1
|
collagen, type XVII, alpha 1
|
chr7_-_87849366
|
0.166
|
NM_003130
|
SRI
|
sorcin
|
chr3_-_9291251
|
0.164
|
NM_001033117
NM_014850
|
SRGAP3
|
SLIT-ROBO Rho GTPase activating protein 3
|
chr1_+_160175114
|
0.164
|
NM_003768
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
chr14_+_20937537
|
0.161
|
NM_000270
|
PNP
|
purine nucleoside phosphorylase
|
chr12_-_54673901
|
0.161
|
NM_012117
|
CBX5
|
chromobox homolog 5
|
chr5_+_86564727
|
0.157
|
NM_022650
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
chr5_+_34687663
|
0.157
|
NM_001145523
|
RAI14
|
retinoic acid induced 14
|
chr2_-_69870976
|
0.157
|
NM_014911
|
AAK1
|
AP2 associated kinase 1
|
chr22_-_44258210
|
0.156
|
NM_014351
|
SULT4A1
|
sulfotransferase family 4A, member 1
|
chr15_+_42066631
|
0.156
|
NM_001128608
NM_014994
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1
|
chr5_+_140771482
|
0.156
|
NM_014004
NM_032088
|
PCDHGA8
|
protocadherin gamma subfamily A, 8
|
chr8_-_98290171
|
0.156
|
NM_033512
|
TSPYL5
|
TSPY-like 5
|
chr5_+_86564044
|
0.155
|
NM_002890
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
chr10_+_124134093
|
0.154
|
NM_001001974
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
chr4_+_154125589
|
0.153
|
NM_015271
|
TRIM2
|
tripartite motif containing 2
|
chr3_+_118892363
|
0.153
|
NM_006952
|
UPK1B
|
uroplakin 1B
|
chr1_-_208417635
|
0.150
|
NM_025179
|
PLXNA2
|
plexin A2
|
chr3_-_124606129
|
0.150
|
NM_002213
|
ITGB5
|
integrin, beta 5
|
chr1_-_114430168
|
0.149
|
NM_001010922
|
BCL2L15
|
BCL2-like 15
|
chr1_+_109656570
|
0.148
|
NM_020775
|
KIAA1324
|
KIAA1324
|
chr7_-_30029284
|
0.148
|
NM_001145515
NM_014766
NM_001145513
|
SCRN1
|
secernin 1
|
chr22_+_32340435
|
0.148
|
NM_003405
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide
|
chr2_+_46524448
|
0.147
|
NM_001430
|
EPAS1
|
endothelial PAS domain protein 1
|
chr10_+_124145584
|
0.146
|
NM_001195608
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
chr11_-_10562689
|
0.146
|
NM_016422
|
RNF141
|
ring finger protein 141
|
chr4_+_154074269
|
0.145
|
NM_001130067
|
TRIM2
|
tripartite motif containing 2
|
chr7_-_108096693
|
0.145
|
NM_001193582
NM_001193583
NM_001193584
NM_005010
|
NRCAM
|
neuronal cell adhesion molecule
|
chr15_-_101792125
|
0.144
|
NM_014918
|
CHSY1
|
chondroitin sulfate synthase 1
|
chrX_+_9754465
|
0.144
|
NM_001649
|
SHROOM2
|
shroom family member 2
|
chr14_+_70078309
|
0.144
|
NM_014734
|
KIAA0247
|
KIAA0247
|
chr3_+_51422691
|
0.144
|
NM_006010
|
MANF
|
mesencephalic astrocyte-derived neurotrophic factor
|
chr12_+_56915587
|
0.143
|
NM_002898
|
RBMS2
|
RNA binding motif, single stranded interacting protein 2
|
chr17_+_5973640
|
0.143
|
NM_015253
|
WSCD1
|
WSC domain containing 1
|
chr2_+_241375030
|
0.143
|
NM_002081
|
GPC1
|
glypican 1
|
chr5_+_140734767
|
0.141
|
NM_018917
NM_032053
|
PCDHGA4
|
protocadherin gamma subfamily A, 4
|
chr10_+_124151818
|
0.140
|
NM_021622
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
chr2_+_64681270
|
0.139
|
NM_014181
|
LGALSL
|
lectin, galactoside-binding-like
|
chr5_+_34656367
|
0.139
|
NM_001145522
NM_015577
|
RAI14
|
retinoic acid induced 14
|
chr14_+_77228132
|
0.136
|
NM_014909
|
VASH1
|
vasohibin 1
|
chr10_-_45474210
|
0.136
|
NM_007021
|
C10orf10
|
chromosome 10 open reading frame 10
|
chr5_+_34656595
|
0.136
|
NM_001145520
|
RAI14
|
retinoic acid induced 14
|
chr17_-_7578810
|
0.136
|
NM_001126115
NM_001126116
NM_001126117
|
TP53
|
tumor protein p53
|
chr3_-_15374082
|
0.136
|
NM_004844
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
chr7_-_5553305
|
0.134
|
NM_024963
|
FBXL18
|
F-box and leucine-rich repeat protein 18
|
chr2_+_31456879
|
0.132
|
NM_014600
|
EHD3
|
EH-domain containing 3
|
chr20_+_37434294
|
0.131
|
NM_001172735
NM_015568
|
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B
|
chr5_+_34684611
|
0.130
|
NM_001145521
NM_001145525
|
RAI14
|
retinoic acid induced 14
|
chr3_+_133293256
|
0.130
|
NM_001134423
|
CDV3
|
CDV3 homolog (mouse)
|
chr22_+_38302085
|
0.128
|
NM_033386
|
MICALL1
|
MICAL-like 1
|
chr11_-_79151694
|
0.127
|
NM_001098816
|
ODZ4
|
odz, odd Oz/ten-m homolog 4 (Drosophila)
|
chr12_-_58160823
|
0.126
|
NM_000785
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
chr16_-_4588379
|
0.126
|
NM_001199054
|
C16orf5
|
chromosome 16 open reading frame 5
|
chr22_-_38668966
|
0.125
|
NM_001195072
NM_012264
|
TMEM184B
|
transmembrane protein 184B
|
chr5_-_125930604
|
0.124
|
NM_001182
NM_001201377
NM_001202404
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
chr20_+_25228698
|
0.123
|
NM_002862
|
PYGB
|
phosphorylase, glycogen; brain
|
chr3_-_149421059
|
0.123
|
NM_001168278
|
WWTR1
|
WW domain containing transcription regulator 1
|
chr4_+_148402068
|
0.122
|
NM_001166055
NM_001957
|
EDNRA
|
endothelin receptor type A
|
chr16_+_68771192
|
0.122
|
NM_004360
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
chr3_-_15382874
|
0.122
|
NM_001018009
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
chr2_-_20425166
|
0.122
|
NM_001006946
|
SDC1
|
syndecan 1
|
chr5_+_140723600
|
0.120
|
NM_018916
NM_032011
|
PCDHGA3
|
protocadherin gamma subfamily A, 3
|
chrX_+_73641084
|
0.118
|
NM_006517
|
SLC16A2
|
solute carrier family 16, member 2 (monocarboxylic acid transporter 8)
|
chr5_-_64777703
|
0.117
|
NM_197941
|
ADAMTS6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6
|
chr22_-_38668669
|
0.117
|
NM_001195071
|
TMEM184B
|
transmembrane protein 184B
|
chr2_+_74881353
|
0.117
|
NM_004263
|
SEMA4F
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F
|
chr17_-_4269814
|
0.115
|
NM_003342
|
UBE2G1
|
ubiquitin-conjugating enzyme E2G 1
|
chr20_-_50384899
|
0.115
|
NM_006045
|
ATP9A
|
ATPase, class II, type 9A
|
chr19_+_17622420
|
0.114
|
NM_012088
|
PGLS
|
6-phosphogluconolactonase
|
chr5_+_140800536
|
0.114
|
NM_018914
NM_032091
NM_032092
|
PCDHGA11
|
protocadherin gamma subfamily A, 11
|
chr16_+_28962127
|
0.114
|
NM_032815
|
NFATC2IP
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein
|
chr1_+_157963062
|
0.114
|
NM_018240
|
KIRREL
|
kin of IRRE like (Drosophila)
|
chr17_-_7590731
|
0.113
|
NM_000546
NM_001126112
NM_001126113
NM_001126114
|
TP53
|
tumor protein p53
|
chr3_+_50192847
|
0.113
|
NM_004186
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
chr3_+_133292404
|
0.113
|
NM_001134422
NM_017548
|
CDV3
|
CDV3 homolog (mouse)
|
chr15_-_45815001
|
0.113
|
NM_013309
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4
|
chr2_-_20424627
|
0.112
|
NM_002997
|
SDC1
|
syndecan 1
|
chr5_-_107006585
|
0.109
|
NM_001962
|
EFNA5
|
ephrin-A5
|
chr5_+_72921980
|
0.109
|
NM_001080479
NM_001177693
|
RGNEF
|
190 kDa guanine nucleotide exchange factor
|
chr2_-_136875629
|
0.109
|
NM_003467
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
chr4_-_139163222
|
0.107
|
NM_014331
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
chr6_-_116601102
|
0.107
|
NM_003309
|
TSPYL1
|
TSPY-like 1
|
chr2_+_85811530
|
0.107
|
NM_006634
|
VAMP5
|
vesicle-associated membrane protein 5 (myobrevin)
|
chr6_-_32821743
|
0.106
|
NM_000593
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
chr15_-_23086290
|
0.106
|
NM_144599
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
chr3_-_149375584
|
0.105
|
NM_001168280
NM_015472
|
WWTR1
|
WW domain containing transcription regulator 1
|
chr11_+_119076974
|
0.105
|
NM_005188
|
CBL
|
Cas-Br-M (murine) ecotropic retroviral transforming sequence
|
chrX_+_15525430
|
0.103
|
NM_001721
|
BMX
|
BMX non-receptor tyrosine kinase
|
chr22_-_36424397
|
0.101
|
NM_001082578
NM_001082579
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2
|
chr1_+_164528586
|
0.101
|
NM_001204961
NM_001204963
NM_002585
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
chr19_+_8478181
|
0.101
|
NM_001005415
NM_001005416
NM_016496
|
MARCH2
|
membrane-associated ring finger (C3HC4) 2
|
chr3_+_107241782
|
0.101
|
NM_001142568
NM_020235
|
BBX
|
bobby sox homolog (Drosophila)
|
chr3_+_112280871
|
0.100
|
NM_017945
|
SLC35A5
|
solute carrier family 35, member A5
|
chr9_+_139560193
|
0.099
|
NM_201446
|
EGFL7
|
EGF-like-domain, multiple 7
|
chr22_-_45608346
|
0.098
|
NM_015264
|
KIAA0930
|
KIAA0930
|
chr20_+_55204307
|
0.097
|
NM_003222
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
chr19_+_54385429
|
0.097
|
NM_002739
|
PRKCG
|
protein kinase C, gamma
|
chr16_-_4588738
|
0.097
|
NM_001199055
NM_001199056
NM_013399
|
C16orf5
|
chromosome 16 open reading frame 5
|
chr12_-_54982271
|
0.096
|
NM_006741
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
chr1_-_175161832
|
0.096
|
NM_001162895
NM_014656
NM_001162893
NM_001162894
|
KIAA0040
|
KIAA0040
|
chr6_+_42018250
|
0.095
|
NM_138572
|
TAF8
|
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa
|
chr5_+_140855543
|
0.094
|
NM_002588
NM_032402
NM_032403
|
PCDHGC3
|
protocadherin gamma subfamily C, 3
|
chr10_+_128593994
|
0.093
|
NM_001380
|
DOCK1
|
dedicator of cytokinesis 1
|
chr1_+_169075869
|
0.093
|
NM_001677
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
chr2_-_136873740
|
0.092
|
NM_001008540
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
chr5_-_148442606
|
0.092
|
NM_024577
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
chr15_-_34331185
|
0.092
|
NM_020371
|
AVEN
|
apoptosis, caspase activation inhibitor
|
chr8_-_67525426
|
0.092
|
NM_001080416
NM_001144755
|
MYBL1
LOC645895
|
v-myb myeloblastosis viral oncogene homolog (avian)-like 1
uncharacterized LOC645895
|
chrX_+_80457302
|
0.092
|
NM_003022
|
SH3BGRL
|
SH3 domain binding glutamic acid-rich protein like
|
chr9_+_139557378
|
0.091
|
NM_016215
|
EGFL7
|
EGF-like-domain, multiple 7
|
chr11_+_32851469
|
0.091
|
NM_024081
|
PRRG4
|
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)
|
chr8_-_22549901
|
0.090
|
NM_001199880
|
EGR3
|
early growth response 3
|
chr4_-_84030995
|
0.090
|
NM_001130716
|
PLAC8
|
placenta-specific 8
|